FDA-approved Latisse 0.03 percent a new topical drug conveniently packaged for a 30-day supply. Each 30-day supply consists of 60 single use sterile applicators manufactured by the cosmetic/plastic surgery titan Allergan Corporation based in Irvine, California. The product is easily applied to the upper lash line and can begin to produce noticeable thickening, darkening as well as increased lash length of the upper lash line for which it was approved in approximately eight to 10 weeks with full results usually achieved by 16 to 18 weeks. Sometime this spring, Allergan Corporation will release this product by prescription only.
Ophthalmologists first began to serendipitously discover the thickening, darkening and lengthening of the lash line during the treatment of the eye disorder glaucoma. The eye drops used to treat glaucoma contain prostaglandins, which are believed to cause this effect. Allergan Corporation and their extensive research department continued to refine and perfect Latisse for maximal effect and safety. Bimatoprost is the active ingredient (prostaglandin) in Latisse.
Latisse is now available and the plastic surgery as well as cosmetic industry is very excited to be able to offer this new product. It is important to discuss your medical history with your physician especially patients who have glaucoma and are taking the drug Lumigan. Most commonly reported side effects are eye redness, darkening of the eyelids and itching. To maintain the desired results the patient needs to continue the once-a-day application of Latisse, however if the patient decides to discontinue treatment for whatever reason, not to worry as the upper lash line will return to its pre-treatment state (to dispel any unban rumors/legends that if treatment is stopped the upper eyelashes fall out completely).
Latisse is a very much anticipated and exciting Allergan Product (Allergan Corporation is also is the pioneer and leader who produces Botox) to the aesthetic industry.
For more information, please call 661-273-6666 or the answering service at 818-332-1441. Offices are located in Palmdale at 41230 11th Street West, Suite D, or Valencia at 23501 Cinema Drive, Suite 100. Visit www.davidfellowsmd.com .